SpringerProtocols: Abstract: Clinical Assessment in Psychiatric Genetics

Clinical Assessment in Psychiatric Genetics

By: Philip Gorwood³

Abstract

Full Text

Download PDF (278K)

The use of reliable instruments to collect relevant data in psychiatry is required before studying determinants of psychiatric disorders. Although genetic research in psychiatry devotes large sums of money to biological studies, the investment made in time and effort to describe the clinical features of the subjects being studied is often lacking. Variation of types and amount of clinical information available, psychopathological explanations of the information collected, and differences in definitions of disorders probably explain great discrepancies of results before the 70s.

Affiliation(s): (3) Service de Psychiatrie (Pr Ades), Häpital Louis Mourier, 92700 Colombes Cedex, France

Book Title: Psychiatric Genetics: Methods and Reviews

Series: Methods in Molecular Medicine | Volume: 77 | Pub. Date: Sep-10-2002 | Page Range: 99-126 | DOI: 10.1385/1-59259-348-8:99

Subject: Neuroscience

References

Download References

1.	Endicott J. (2001) Good diagnoses require good diagnosticians: collecting and integrating the data. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105, 48–49. <Occurrence Type="DOI"><Handle>10.1002/1096-8628(20010108)105:1<48::AID-AJMG1057>3.0.CO;2-M</Handle></Occurrence>

2.	Tsuang M., Faraone S., and Lyons M. (1993) Identification of the phenotype in psychiatric genetics. Eur. Arch. Psychiatry Clin. Neurosci. 243, 131–142.

3.	Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., et al. (1994) A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol. 55, 149–158.

4.	Crocq M.A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., et al. (1992) Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 29, 858–860.

5.	Nanko S., Fukuda R., Hattori M., Sasaki T., Dai X.Y., Yamaguchi K., et al. (1994) Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus. Am. J. Med. Genet. 15, 264–267.

6.	Kennedy J.L., Billett E.A., Macciardi F.M., Verga M., Parsons T.J., Meltzer H.Y., et al. (1995) Association study of dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 60, 558–562.

7.	Griffon N., Crocq M.A., Pilon C., Martres M.P., Mayerova A., Uyanik G., et al. (1996) Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am. J. Med. Genet. 67, 63–70. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19960216)67:1<63::AID-AJMG11>3.0.CO;2-N</Handle></Occurrence>

8.	Williams J., Spurlock G., Holmans P., Mant R., Murphy K., Jones L., et al. (1998) A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol. Psychiatry 3, 141–149.

9.	Dubertret C., Gorwood P., Adés J., Feingold J., Schwartz J.C., Sokoloff P. (1998) A meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in caucasians. Am. J. Med. Genet. (Neuropsychiat. Genet.) 81, 318–322. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19980710)81:4<318::AID-AJMG8>3.0.CO;2-P</Handle></Occurrence>

10.	Steen V.M., Lovlie R., MacEwan T., and McCreadie R.G. (1997) Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol. Psychiatry 2, 139–145.

11.	Segman R.H., Heresco-Levy U., Finkel B., Inbar R., Neeman T., Schlafman M., et al. (2000) Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology (Berl) 152, 408–413.

12.	Eichhammer P., Albus M., Borrmann-Hassenbach M., Schoeler A., Putzhammer A., Frick U., et al. (2000) Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen’s study on DRD3 and tardive dyskinesia. Am. J. Med. Genet. 96, 187–191. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8</Handle></Occurrence>

13.	Segman R., Neeman T., Heresco-Levy U., Finkel B., Karagichev L., Schlafman M., et al. (1999) Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol. Psychiatry 4, 247–253.

14.	Basile V.S., Masellis M., Badri F., Paterson A.D., Meltzer H.Y., Lieberman J.A., et al. (1999) Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 21, 17–27. <Occurrence Type="DOI"><Handle>10.1016/S0893-133X(98)00114-6</Handle></Occurrence>

15.	Browne S., Clarke M., Gervin M., Lane A., Waddington J.L., Larkin C., et al. (2000) Determinants of neurological dysfunction in first episode schizophrenia. Psychol. Med. 30, 1433–1441.

16.	Dubertret C., Gorwood P., Gouya L., Deybach J.C., Feingold J., and Adés J. (2001) Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr. Res. 49(1-2): 203–212. <Occurrence Type="DOI"><Handle>10.1016/S0920-9964(00)00085-2</Handle></Occurrence>

17.	Van Tol H.H.M., Bunzow J.R., Guan H.C., et al. (1991) Cloning of the gene for human D4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610–619.

18.	Serretti A., Macciardi F., Catalano M., Bellodi L., and Smeraldi E. (1999) Genetic variants of dopamine receptor D4 and psychopathology. Schizophr. Bull. 25, 609–618.

19.	Kaiser R., Konneker M., Henneken M., Dettling M., Muller-Oerlinghausen B., Roots I., et al. (2000) Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol. Psychiatry 5, 418–424.

20.	Meyer J., Huberth A., Ortega G., Syagailo Y.V., Jatzke S., Mossner R., et al. (2001) A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol. Psychiatry 6, 302–306.

21.	Noble E.P., Zhang X., Ritchie T.L., and Sparkes R.S. (2000) Haplotypes at the DRD2 locus and severe alcoholism. Am. J. Med. Genet. 96, 622–631. <Occurrence Type="DOI"><Handle>10.1002/1096-8628(20001009)96:5<622::AID-AJMG7>3.0.CO;2-5</Handle></Occurrence>

22.	Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., et al. (1997) Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry 41, 229–304. <Occurrence Type="DOI"><Handle>10.1016/S0006-3223(96)00044-3</Handle></Occurrence>

23.	Schmidt L.G., Harms H., Kuhn S., Rommelspacher H., and Sander T. (1998) Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am. J. Psychiatry 155,474–478.

24.	Gorwood P., Batel P., Adés J., Hamon M., and Boni C. (2000) Serotonin transporter gene polymorphisms, alcoholism and suicidal behaviour. Biol. Psychiatry 48, 259–264. <Occurrence Type="DOI"><Handle>10.1016/S0006-3223(00)00840-4</Handle></Occurrence>

25.	Saccone N.L., Kwon J.M., Corbett J., Goate A., Rochberg N., Edenberg H.J., et al. (2000) A genome screen of maximum number of drinks as an alcoholism phenotype. Am. J. Med. Genet. 96, 632–637. <Occurrence Type="DOI"><Handle>10.1002/1096-8628(20001009)96:5<632::AID-AJMG8>3.0.CO;2-#</Handle></Occurrence>

26.	Lappalainen J., Long J.C., Eggert M., Ozaki N., Robin R.W., Brown G.L., et al. (1998) Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry 55, 989–994.

27.	Eaton W., Neufeld K., Chen L.S., and Cai G. (2000) A comparison of self-report and clinical diagnostic interviews for depression. Arch. Gen. Psychiatry 57, 217–222.

28.	American Psychiatric Association. (2000) Handbook of Psychiatric Measures. American Psychiatric Association, ed., Washington, DC.

29.	Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. (1994) Diagnostic Interview for Genetic Studies: rational, unique features, and training. Arch. Gen. Psychiatry 51, 849–862.

30.	Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., Jr., et al. (1994) A new, semistructured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol. 55, 149–158.

31.	Hesselbrock M., Easton C., Bucholz K., Schuckit M., and Hesselbrock V. (1992) A validity study of the SSAGA-a comparison with the SCAN. Addiction 94, 1361–1370.

32.	Spitzer R.L., Williams J.B., Gibbon M., and First M.B. (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatry 49, 624–629.

33.	First M., Spitzer R., Williams J., et al. (1995) Structured clinical interview for DSM-IV (SCID-I) (User’s guide and interview) research version. Biometrics Research Department, New York Psychiatric Institute New York, NY.

34.	First M., Spitzer R., Williams J., et al. (1997) Structured clinical interview for DSM-IV-Clinician Version (SCID-CV) (User’s guide and interview) American Psychiatric Press Washington, DC.

35.	Williams J.B., Gibbon M., First M.B., Spitzer R.L., Davies M., Borus J., et al. (1992) The Structured Clinical Interview for DSMIII-R (SCID). II. Multisite test-retest reliability. Arch. Gen. Psychiatry 49, 630–636.

36.	Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., et al. (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch. Gen. Psychiatry 47, 589–593.

37.	Farmer A., Cosyns P., Leboyer M., et al. (1993) A SCAN-SADS comparison study of psychotic subjects and their first-degree relatives. Eur. Arch. Psychiatry Clin. Neurosci. 242, 352–356.

38.	Endicott J. and Spitzer R.L. (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35, 837–844.

39.	Andreasen N.C., Flaum M., and Arndt S. (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49, 615–623.

40.	Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.F., Burke J., et al. (1988) The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 45, 1069–1077.

41.	Robins L.N., Helzer J.E., Croughan J., and Ratcliff K.S. (1981) National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch. Gen. Psychiatry 38, 381–389.

42.	Frances A. (1998) Problems in defining clinical significance in epidemiological studies. Arch. Gen. Psychiatry 55, 119.

43.	Wittchen H.U., Robins L.N., Cottler L.B., Sartorius N., Burke J.D., and Regier D. (1991) Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br. J. Psychiatry 159, 645–658.

44.	Spitzer R.L., Williams J.B., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., et al. (1994) Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272, 1749–1756.

45.	Broadhead W.E., Leon A.C., Weissman M.M., Barrett J.E., Blacklow R.S., Gilbert T.T., et al. (1995) Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch. Fam. Med. 4, 211–219.

46.	Lecrubier Y., Sheehan D., Weiller E., et al. (1997) The Mini-International Neuropsychiatric Interview (MINI): a short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry 12, 224–231. <Occurrence Type="DOI"><Handle>10.1016/S0924-9338(97)83296-8</Handle></Occurrence>

47.	Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59S, 22–33.

48.	McGuffin P., Farmer A., and Harvey I. (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 48, 764–770.

49.	Williams J., McGuffin P., et al. (1996) A multicenter reliability study of the OPCRIT computerised diagnostic system. Psychol. Medicine 26(4), 775–783.

50.	Craddock M., Asherson P., Owen M.J., Williams J., McGuffin P., and Farmer A.E. (1996) Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br. J. Psychiatry 169, 58–63.

51.	Azevedo M.H., Soares M.J., Coelho I., Dourado A., Valente J., Macedo A., et al. (1999) Using consensus OPCRIT diagnoses. An efficient procedure for best-estimate lifetime diagnoses. Br. J. Psychiatry 175, 154–157.

52.	Hasin D.S., Trautman K.D., Miele G.M., Samet S., Smith M., and Endicott J. (1996) Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am. J. Psychiatry 153, 1195–1201.

53.	Andreasen N.C., Endicott J., Spitzer R.L., and Winokur G. (1977) The family history method using diagnostic criteria. Reliability and validity. Arch. Gen. Psychiatry 34, 1229–1235.

54.	Chapman T.F., Mannuzza S., Klein D.F., and Fyer A.J. (1994) Effects of informant mental disorder on psychiatric family history data. Am. J. Psychiatry 151, 574–579.

55.	Rice J.P., Reich T., Bucholz K.K., Neuman R.J., Fishman R., Rochberg N., et al. (1995) Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin. Exp. Res. 19, 1018–1023.

56.	Weissman M., et al. (2000) Brief screening for family psychiatric history. The family history screen. Arch. Gen. Psychiatry 57, 675–682.

Comments (Loading...)

Post comment/View all comments